World congress, IHPBA, Geneva, Switzerland, Sept 5th 2018. Neoadjuvant and adjuvant therapy in Gall Bladder cancers.
ESMO breast cancer in young women, Lugano, Switzerland, Oct 8th, 2018- Implementing guidelines in LMICs
10th UAE cancer congress, Dubai, 11th Oct 2018: Debate: 6 months of Trastuzumab is appropriate for most patients with HER 2 positive breast cancer requiring adjuvant treatment.
10th UAE cancer congress , Dubai, 13th Oct 2018, Rectal cancer after neoadjuvant therapy with complete clinical response
10th UAE cancer congress , Dubai, 13th Oct 2018 : MDT case discussion on HCC
CMT Local Teaching, Oncological emergencies, London. April 10th, 2018.
Adjuvant therapy in women with breast cancer, Barts Health, London, Mar 26th, 2018.
Prevention of common cancers – Work and Cancer meeting at the Royal Society of Medicine, London, March 28th, 2018
Systemic therapy in patients with early breast cancer- Barts health and Homerton Study day, London, March 21st, 2018
Cancer awareness in women, Telangna Jagruti UK, London, March 10th, 2018
Second Sudan International Breast Cancer conference, Updates in triple negative breast cancer. Feb 25th, 2018
MSc course in Oncology, Breast Cancer, QMUL, London Jan 24th, 2018
Clinical efficacy into Clinical Practice. Managing patients with metasatic breast cancer, ER pos, Her 2 neg. London. Jan 17th, 2018
Decoding Cancer, Personalised vs. Precision Medicine in Clinics. RSM, London, Dec 14th, 2017
CMT Local Teaching, Oncology for Non-Oncologists. London. Oct 31st, 2017
Patient stratification in neoadjuvant setting: determining optimal therapeutic response. British Library, London . Sept 22nd, 2017
Treatment sequencing in advanced breast cancer, Case discussion, metastatic breast cancer. RCP, London Sept 20th ,2017
Cardio-Oncology Training day. Cardiovascular Toxicities of Breast Cancer Treatment: An Oncologist’s perspective, RSM, London Sept 18th, 2017
Palliative Medicine Study day. Advanced breast Cancer- treatment options. Sept 12th, 2017
Nag Foundation Breast Oncology Forum . Keynote Lecture, Overcoming Endocrine and HER2 Resistance in Metastatic Breast cancer. Pune, India Aug 19th, 2017
Prevention of gynaecological Cancers- evidence and possibility in India. Updates in Oncology, NCI-AIIMS initiative, New Delhi, Aug 5th, 2017
Pink Ribbon. Oncologist focus: New drug possibilities, personalized medicine, genomics, RSM, London . March 23rd, 2017
Neoadjuvant therapy for gall bladder cancer- is there a role? UAE Cancer congress 2014, Dubai, Oct 30-31st, 2014
Debate on Neoadjuvant therapy for borderline resectable pancreatic cancer- Yes. UAE Cancer congress 2014, Dubai, Oct 30-31st, 2014
Neuroendocrine tumours, an overview. Panel discussion on case based discussions. NET India forum, Chandigarh, Jul 26th 2014.
Medical management of NET, and case based panel discussion. NET India forum, Meerut, May 11th, 2014
Medical management of metastatic GEPNET- role of chemotherapy and targeted therapy. ILBS Cancer Update, New Delhi, May 3rd, 2014
Molecular targets and targeted therapy in pancreatic cancer- current status. XIX SGE week, advanced course in pancreatic surgery. Lucknow, April 4th, 2014
Multimodal approach to pancreatic cancer- cased based panel discussion. IHPBA- India, Mumbai, Jan 9th-12th, 2014.
Metastatic colorectal cancer – case based panel discussion. IHPBA- India, Mumbai, Jan 9th-12th, 2014.
Metastatic pancreatic cancer. IHPBA- India, Mumbai, Jan 9th-12th, 2014.
Debate on Neoadjuvant therapy for borderline resectable pancreatic cancer- Yes. IHPBA- India, Mumbai, Jan 9th-12th, 2014.
Sorafenib, TMH experience, IHPBA- India, Mumbai, Jan 9th-12th, 2014.
Management of gastric cancer- neoadjuvant, adjuvant and palliative therapy. Association of surgeons of India, ASICON, Ahmedabad, Dec 27th, 2013
Plenary on Multidisciplinary management of neuroendocrine tumours, Society of Nuclear medicine of India conference, SNMICON, Mumbai, Dec 15th 2013
Adjuvant treatment of pancreatic cancer: what is the best regimen? - The case for gemcitabine, Case discussion on GI cancers, Neoadjuvant approaches to upper and mid rectal tumours. First Asia-Pacific gastroenterology cancer symposium, APGCS, Singapore, 6th-8th Dec 2013
Update on breast cancer and gastric cancer. Goa Medical College, Goa, 30th Nov 2013
Metastatic colorectal cancer-Indian perspective. First Indian Cancer congress. New Delhi, Nov 22-24th 2013
Controversies in neoadjuvant treatment in locally advanced rectal cancer. First Indian Cancer congress. New Delhi, Nov 22-24th 2013
GIST- chemotherapy and targeted therapy, ISO session. First Indian Cancer congress. New Delhi, Nov 22-24th 2013
Aflibercept-TMH experience. First Indian Cancer congress. New Delhi, Nov 22-24th 2013
Borderline resectable colorectal liver metastases- role of chemotherapy, controversies in neoadjuvant therapy of rectal cancers, First Indian Cancer congress – New Delhi, Nov 22-24th 2013
Asia Pacific south Africa (APSA) Publication Training Workshop, -Publication experience, Hyderabad, Nov 9-10th, 2013
Case based panel discussion. 1st Asia Pacific Neuroendocrine Tumour Society APNETS, Kuala Lumpur, Oct 25-27th, 2013
Side effects of chemotherapy and hormone therapy, 2nd National Breast cancer survivors conference, Nasik, Oct 19th, 2013
Optimal neoadjuvant therapy for pancreatic cancers, Optimal neoadjuvant therapy for rectal cancers, panel discussion on metastatic pancreatic cancer, UAE Cancer Congress 2013, Dubai, Oct 4th-5th, 2013
Early breast cancer- endocrine therapy; Metastatic breast cancer –overcoming endocrine resistance; 5th Muscat International Oncology Conference, Muscat; 17th – 18th September 2013.
Molecular oncology in upper GI cancers, 29th ICON, Jaipur, Sept 13-15th 2013
Management of advanced pancreatic cancer, RCC Trivandrum, 27th July 2013
Adjuvant and neoadjuvant therapy for gall bladder cancers-IHPBA-India, Patna, 21st July 2013
Management of breast cancer, Mahaveer Cancer Sansthan, Patna, 20th July 2013
Case based discussion – Breast cancer, metastatic colorectal cancer – Indian perspective, Best of ASCO 2013, Mumbai, June 28-30th, 2013.
What are the local factors to consider when selecting appropriate VAD for Oncology and Haematology patients? TMH VAD workshop, Mumbai, June 21st , 2013
Approach to diagnosis of Cancers, TMH –PGIMER CME for local doctors and nurses, Chandigarh, May 19th, 2013
Management Of Side Effects Of Chemotherapy & Endocrine Therapy, Association of Breast surgeons of India annual meeting, Chandigarh, May 18th, 2013.
Multiorgan dysfunction syndrome. 39th Annual Meeting Of The European Group Of Blood & Marrow Transplantation London, 9th April 2013
Diagnosis and treatment of GI cancers, CME, Sangrur, Punjab, Apr 6th, 2013
Management of neuroendocrine tumours, what difference have the newer drugs made? Global Oncology Summit 2013. Hyderabad, 31st Mar 2013.
Adjuvant therapy of gastric cancer, Evidence Based Management Of Cancers, Mumbai, 1st – 3rd March 2013
Recent Advances In The Management Of Breast Cancer, Meerut ONCON, Meerut, 24th Feb 2013
Evidence for prevention of breast cancer, Workshop on cost-effectiveness analysis in breast cancer policy development, Mumbai, 20th – 22nd Feb 2013
Moderator, case capsule of rectal NET, RGCON 2013, 17th Feb 2013, New Delhi
Role Of Adjuvant therapy in Resectable Gastric Carcinoma, Cancer- CI, Hyderabad, 10th Feb 2013
Controversies in Breast Cancer meeting, 9th Feb 2013, Kolkata,
Chemoprophylaxis in mutation carriers, Indian Cancer Genetics conference 2013 (Indo-UK collaboration) ACTREC, Mumbai, 25th Jan 2013
ESMO 2012 highlights for colorectal cancers, ESMO guidelines group meeting, Chennai, 22nd Dec 2012
Case capsule discussion on colorectal cancers, Colorectal Cancer Symposium 2012, Mumbai, 8th Nov 2012
Moderator: Case capsules of HCC, Asia pacific Virtual Meeting on Expert discussion on HCC management Mumbai, 3rd Nov 2012,
Side effects of chemotherapy in breast cancer, 1st national breast cancer support group meeting, Pune, 6th Oct 2012
Pathological CR in rectal cancers, Zoledronic acid in breast cancers, Neo-adjuvant approaches in GI cancers, UAE Cancer congress, Dubai, 12-14th Oct 2012
Moderator, Case capsule discussion on colon cancer, 27th ICON, Nasik, 15th Sept 2012
Recent Advances in Surgical & Medical Gastroenterology-Elsevier workshop. Targeted therapy in GI cancers, Bali, Indonesia, 21st July 2012
ICMR Task force on cancer guidelines-chairmen’s meeting, Talk on common template for the guidelines, New Delhi, 29th June 2012
Long term survival of EORTC study-colorectal cancer, Advances in Chemotherapy on upper GI cancers, chemotherapy standards in metastatic colorectal cancer, Best of ASCO, Jaipur, 23rd June 2012.
Advanced EBMT Training Course on European Approach to the Medical Management of Mass Radiation Exposure. Multi-organ dysfunction syndrome. 4th April 2012, Geneva
Hormone therapy and biomarkers in breast cancer- moderator. 26th ICON. 24th March 2012, Bangalore
Debate on loco-regional issues in breast cancer- moderator. Asia Breast Cancer Congress (ABCC). 4th March 2012, Bangalore
Panel discussion on Hodgkin Lymphoma. EBM, TMC 24th February 2012, Mumbai
Modern management of colorectal cancers – RGCI GI Cancers Symposium, – 17th February 2012, New Delhi
Role of Physicians in Cancer Care - IMA Dwarka. January 13, 2012.
GIST – targeted therapy. Delhi NCR Oncology Meet, India Habitat Centre, January 11, 2012.
Hodgkin Lymphoma and elderly patients- moderator for the session. European School of Oncology: Conference on Lymphoma’s and Leukaemia’s, Hotel ITC Grand Central, Mumbai, January 6, 2012.
Lung cancer – interactive case presentation. National College of Chest Physicians (I), Monthly Clinical Meetings, India Habitat Centre, New Delhi, 18th December 2011
CLABSI (Central line associated blood stream infections) - A Clinicians Perspective”. Hospital Infection Society – India (HISI meeting), Gurgaon, 17th December 2011
Role of Physician in cancer care. Gurgaon Nursing home and diagnostic centre association meeting, Gurgaon, 4th Nov 2011
Molecular profiling: Heterogeneity of adenocarcinoma and targets of therapy. F-KOM, Gurgaon. 22nd Oct 2011
Chemotherapy update from the latest EBCTCG overview-implications for standard practice. TMC-WCI conference, Mumbai. 14th Oct 2011.
Oncology for non-oncologists- primary and emergency care. Artemis Cancer Centre, Gurgaon. 20th Sept 2011
Role of Physicians in diagnosis and staging of cancers. CGHS-Delhi and Gurgaon. New Delhi. 14th September 2011.
Invited panellist for case based discussion. NET Expert forum. New Delhi. 3rd Sept 2011
Selection of front-line chemotherapy for advanced non-small cell lung cancer. New Delhi, 30th August 2011
Role of Physician in cancer care. IMA Gurgaon meeting, Gurgaon. 27th August 2011
Invited faculty for the meeting Multi-sectoral Partnerships for Health Promotion and Non- Communicable Diseases (NCDs) Prevention in India, Tata Memorial Hospital, Mumbai, 5th Aug 2011.
Emerging therapies in Multiple Myeloma-Carfilzomib and Pomalidomide, National Myeloma Summit, 6th August 2011, Mumbai
Triple negative breast cancer: Panelist for the abstract discussions, Best of ASCO, Pune 16th July 2011
Eribulin in Metastatic breast cancer: Best of ASCO, Pune 16th July 2011
Neoadjuvant therapy in upper GI Cancers: breakout session at Best of ASCO, Pune 15th July 2011
Chairman, Session on Plasma cell dyscrasias at XIII International Myeloma workshop, Paris, 5th May 2011
Cobalt nuclear accident in Delhi: Education session Nuclear accidents, Paris, 5th April 2011
Albumin-bound Paclitaxel in breast cancer: Indian Society of Medical and Paediatric Oncology meeting, Bhubaneswar, 12th Feb 2011
Session Moderator on Haematological Malignancies, Indian Society of Medical and Paediatric Oncology meeting, Bhubaneswar, 12th Feb 2011
Adjuvant chemotherapy: role of taxanes. TMH-WCI conference, Mumbai 23 Oct 2010
Phase II/III clinical trials in breast Cancer. 23rd ICON. Allahabad. 25th September 2010
Bone pain and Cancer. PromOTE Pain-ONCO CAP CME, New Delhi, 26th September 2010.
Cancer awareness. JCI Karnal. 12th September 2010
Cancer management in the 21st century. Artemis Cancer Centre. Gurgaon. 21st August 2010
Re-biopsy at the time of relapse in patients with advanced breast cancer? Best of ASCO, Hyderabad, 10th July 2010
Chemotherapy trials- first line and beyond in advanced ovarian cancer. Best of ASCO, Hyderabad, 10th July 2010
Tobacco and Cancers. Tobacco Cessation Workshop. New Delhi. 3rd June 2010
Lymphadenopathy- approach to diagnosis. PROMOTE CME. Meerut, 23rd May 2010
Hyperleukocytosis and Hyperviscosity. Haemato-Oncology CME, Max Cancer Centre, New Delhi, 15th May 2010.
Case based discussion. Onco-Cardiology CME. New Delhi, 24th April 2010
Care of venous access devices. CVAD refresher course. New Delhi. 17th April 2010
UK planning in case of a radiation accident. EBMT Education session. Vienna. 23rd March 2010
Cancer awareness, Roorkee. 14th March 2010
METREPOL use in radiation accidents. Department of Health Meeting, London, 12th March 2010
End of Life Care for patients with advanced cancer. Mortality Meeting. Max Healthcare, New Delhi, 9th March 2010.
Cancer awareness. International Women’s day, Chitranjan Park, New Delhi, 8th March 2010
Professional conduct, Etiquette and Ethics- MCI. Max Healthcare, New Delhi, 22 Feb 2010
Breast Cancer. ICON Meeting Kolkata. 20th Feb 2010
Phase III Trial Comparing AC®T with AC®TH with TCH in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study (Slamon D et al) San Antonio 2009 revisited, Mumbai, 14th Feb 2010.
Gene Expression Signatures of PI3K Signaling Are Associated with Low ER Levels and the Luminal B Subtype in Breast Cancer Cell Lines and Human Tumours, and in Patients Predicts Poor Outcome (Creighton CJ et al). San Antonio 2009 revisited, Mumbai, 14th Feb 2010
Targeted therapy in MBC: hits and misses, Bangalore. 5th Feb 2010
Hyperleukocytosis in leukaemia patients. Mortality Meet, Max Healthcare. 12th January 2010
Cancer of oesophagus. Max Cancer Centre GI forum. Noida. 2nd February 2010
Role of physicians in Cancer diagnosis and staging. PROMOTE India, Hyderabad, and 23rd January 2010.
Importance of Living will- dying with dignity. Cansupprt/IRCH Foundation course. 20th January 2010
Mechanisms of Her 2 resistance. OASIS meeting, New Delhi and Bangalore 28th and 29th Oct 2009
Haematological and Oncologic emergencies, Asia Pacific Critical Care Meeting, New Delhi, 6th December 2009
Art of Caring. Max Cancer Centre, New Delhi, 8th December 2009.
Handling of cytotoxic drugs and devices and cross infection control. Nurses training workshop, New Delhi. 3rd and 4th November 2009
ISMPO annual meeting, Srinagar, 24th October 2009
Gene expression profiling in breast cancer. ISMPO annual meeting, Srinagar, 24th October 2009
Oncologic emergencies: Cambridge medical seminars, Churchill College, Cambridge, 22nd November 2008
Anglia Network Tyverb launch meeting: Lapatinib in principle and practice: Insights from clinical experience – what does the evidence tell us? 21st October 2008, Bedford
Breast and cervical cancer awareness: Public health awareness event at Swaminarayan temple, Neasden, London 11th October 2008
Targeted therapy, West Anglia nurses study day. September 30, 2008. Addenbrookes hospital, Cambridge.
Global (US/European) consensus on management of radiation accident victims, Cologne, Germany, 25th September 2008
Use of Tyrosine kinase inhibitors in metastatic breast cancer, 19th Indian Cooperative Oncology Network meeting, 21st September 2008, India
Allogeneic transplantation in 48 patients who received accidental irradiation, 1st April 2008, Florence, EBMT 2008
EBMT preparedness for radiation accidents, Tandem BMT meeting, San Diego, 14th February 2008
Lapatinib in metastatic breast cancer, Edinburgh, 29th January 2008
LEAP: RMH experience, Advisory board, London, 3rd December 2007
Breast cancer and pregnancy: complex care issues. National study day for nurses, 17th September 2007.
Breast Unit Meeting, Royal Marsden Hospital, Platinum’s in triple negative breast cancer, 23rd November 2007
Pre-requisites for designation of hospitals to participate in management of radiation accidents, Munich 30th Nov 2007
Nuclear accidents: what have we learned? Role of EBMT. Gulhane Military Medical Academy, Ankara, Turkey, 24th Nov 2006
Use of monoclonal antibodies in NHL, Multidisciplinary study day, St Raphael’s hospice, 1st June 2006.
New treatments for myeloma, PCT day, Parkside cancer Centre, 1st Feb 2005
Newer agents in Myeloma, IMF Hope Trust and Effectiveness for Myeloma Patients, June 17, 2003
Auto transplantation in Myeloma: Issues? Golden Jubilee of International CME on Transplantation, New Delhi, March 30 2003.
Renal disease in Myeloma, Thames Myeloma Audit, Middlesex, 20th March 2003
Myeloma Update; Regional Study Day for Haematologists, London, 28 November 2002
Current place of auto grafting in acute leukaemia; Regional Study Day for Haematologists, 28 November 2002
High-dose treatment in myeloma- is better? ; South Thames Haematology Specialist committee, BMA House, 17 July 2002
Auto transplantation in myeloma: single centre experience: International Myeloma foundation think-tank meeting, US Virgin Islands, St Johns Retreat, 11-15 May 2002.
Allogeneic stem cell transplantation- current scenario; National CME on Haematopoietic Stem cell Transplantation- 2002, New Delhi, 31st March 2002
Multiple Myeloma-renal outcomes, South West Thames Renal and Transplant Unit, St Helier’s Hospital, 8th March 2002
Review of Amphocil tolerability audit, Pharmacy Summit, New Orleans, 13 April 2002
Fungal infections in patients with haematological malignancies, Pharmacy Summit, New Orleans, 13 April 2002
15th February 2002 Myeloma and high dose chemotherapy Cripps lecture room RMH
Emerging concepts in Myeloma therapy – APICON, Chennai, India, 16th January 2002
Erythropoietin and anaemia: Indian cooperative Oncology Network, Port Blair, India, and 13th January 2002.
Cancer awareness-global scenario. Indian cooperative Oncology Network, Port Blair, India, 12th January 2002.
Autologous Transplantation in Myeloma: Marsden experience, Xth Annual course in Haematology, London, 8th November, 2001
International Myeloma Grand round: Case History presentation, Royal Marsden Hospital, London, 14 June 2001.
Allogeneic stem cell transplantation: marrow versus peripheral blood stem cells, Acute Leukaemia Working Party meeting, Sestri Levante, Genoa, 24th February, 2001
Allogeneic peripheral blood stem cell transplantation, 4th UAE International cancer congress, Abu Dhabi, 31st January 2001
Current Management of Myeloma, 4th UAE International cancer congress, Abu Dhabi, 30th January 2001
High-dose treatment in Acute Lymphoblastic Leukaemia, 4th UAE International cancer congress, Abu Dhabi, 30th January 2001
Stem cell transplantation in myeloma, Armed Forces Medical college, Pune, December 2000
Fungal infections in patients with haematological malignancies: RMH experience, National Haematology meeting, Thessaloniki, Greece, 17th November 2000.
Use of diflucan in Haematological Malignancies, Pfizer global perception meeting, Paris, March 2000
BMT in Myeloma, Regional Study Day in Haematology on Bone Marrow Transplantation, London, 25th November 1999.
State of art therapy in multiple myeloma – Indian Medical Association, Meerut, 15th October 1999
Principles of stem cell transplantation- Indraprastha Apollo Hospital, New Delhi, 14th October 1999
Myeloma and renal failure –therapeutic implications, SMS Medical College, Jaipur; 11th October 1999
“Towards curing Myeloma”; Tata Memorial Hospital, Mumbai 7th October 1999
Bone Marrow Transplantation -International Youth Science Forum, Bud Flanagan. 3rd August 1999.
Spectrum of fungal infections: Marsden experience. EORTC meeting, Nijmegen, Netherlands 14th October 1998